pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or likely to suffer from a respiratory disorder, for improving the stability of a pharmaceutical composition, for improving aerosol dispersion performance of a pharmaceutical composition and to reduce the global warming potential of a pharmaceutical composition.
It is a pharmaceutical composition. the composition comprises: (i) a drug component comprising at least one pharmaceutically acceptable salt of glycopyrrolate； and (ii) a propellant component comprising 1,1-difluoroethane (hfa-152a).trata-se de uma composição farmacêutica. a composição compreende: (i) um componente de fármaco que compreende pelo menos um sal farmaceuticamente aceitável de glicopirrolato； e (ii) um componente propulsor que compreende 1,1-difluoroetano (hfa-152a).
